Zomedica Corp(NYSE MKT:ZOM) 
Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of...
Website: http://www.zomedica.com
Founded: 2013
Full Time Employees: 28
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-09-03
P
O 0.13
H 0.13
L 0.12
C 0.12
V 2,930,502
10EMA 0.12
20EMA 0.12
60EMA 0.12
120EMA 0.12
250EMA 0.12